drugset / Trial / NCT00947687
Safety and Efficacy Study of Inhaled PUR003 on a Controlled Influenza Virus Challenge in Healthy Adult Subjects
Phase 1
Completed
24 enrolled
Pulmatrix Inc.
Quintiles, Inc. · collabRetroscreen Virology Ltd. · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The objectives of the study are to demonstrate the effectiveness, safety and tolerability of multiple daily doses of inhaled PUR003, in comparison with placebo, in healthy adults experimentally inoculated with Influenza A/Wisconsin/67/2005 (H3N2) virus.
Timeline
- Start
- 2009-07
- Primary completion
- 2009-09
- Completion
- 2009-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PUR003 | Unknown | — | Inhaled |
Indications
No indication recorded.